Cargando…

Mass drug administration for malaria

Mostrar otras versiones (1)

BACKGROUND: Studies evaluating mass drug administration (MDA) in malarious areas have shown reductions in malaria immediately following the intervention. However, these effects vary by endemicity and are not sustained. Since the 2013 version of this Cochrane Review on this topic, additional studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Monica P, Hwang, Jimee, Choi, Leslie, Lindblade, Kim A, Kachur, S Patrick, Desai, Meghna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479726/ https://www.ncbi.nlm.nih.gov/pubmed/34585740 http://dx.doi.org/10.1002/14651858.CD008846.pub3

Ejemplares similares

Mass drug administration for malaria
por: Poirot, Eugenie, et al.
Publicado: (2013)

Review of Mass Drug Administration for Malaria and Its Operational Challenges
por: Newby, Gretchen, et al.
Publicado: (2015)

Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China
por: Hsiang, Michelle S, et al.
Publicado: (2013)

Opportunities for Subnational Malaria Elimination in High-Burden Countries
por: Lindblade, Kim A., et al.
Publicado: (2020)

Knowledge of Malaria and Its Association with Malaria-Related Behaviors—Results from the Malaria Indicator Survey, Ethiopia, 2007
por: Hwang, Jimee, et al.
Publicado: (2010)

Severe Morbidity and Mortality Risk From Malaria in the United States, 1985–2011
por: Hwang, Jimee, et al.
Publicado: (2014)

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned
por: Odero, Norbert Awino, et al.
Publicado: (2019)

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trial
por: Samuels, Aaron M., et al.
Publicado: (2017)

Socioeconomic health inequality in malaria indicators in rural western Kenya: evidence from a household malaria survey on burden and care-seeking behaviour
por: Were, Vincent, et al.
Publicado: (2018)

Multidrug-resistant malaria and the impact of mass drug administration
por: Zuber, Janie Anne, et al.
Publicado: (2018)

Malaria Elimination in Costa Rica: Changes in Treatment and Mass Drug Administration
por: Chaves, Luis F., et al.
Publicado: (2020)

A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
por: Agarwal, Aarti, et al.
Publicado: (2013)

Trends in malaria prevalence and health related socioeconomic inequality in rural western Kenya: results from repeated household malaria cross-sectional surveys from 2006 to 2013
por: Were, Vincent, et al.
Publicado: (2019)

Using Respondent Driven Sampling to Identify Malaria Risks and Occupational Networks among Migrant Workers in Ranong, Thailand
por: Wangroongsarb, Piyaporn, et al.
Publicado: (2016)

A stochastic model for the probability of malaria extinction by mass drug administration
por: Pemberton-Ross, Peter, et al.
Publicado: (2017)

Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial
por: Abdelmenan, Semira, et al.
Publicado: (2022)

Mass drug administration can be a valuable addition to the malaria elimination toolbox
por: Eisele, Thomas P.
Publicado: (2019)

Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar
por: Kyaw, Shwe Sin, et al.
Publicado: (2021)

Mass Drug Administration of Artemisinin-piperaquine on High Malaria Epidemic Area
por: Deng, Changsheng, et al.
Publicado: (2014)

How Patients Take Malaria Treatment: A Systematic Review of the Literature on Adherence to Antimalarial Drugs
por: Bruxvoort, Katia, et al.
Publicado: (2014)

It is time to rethink tactics in the fight against malaria
por: Slutsker, Laurence, et al.
Publicado: (2013)

Novel application of one-step pooled molecular testing and maximum likelihood approaches to estimate the prevalence of malaria parasitaemia among rapid diagnostic test negative samples in western Kenya
por: Shah, Monica P., et al.
Publicado: (2022)

Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration
por: Anwar, Md Nurul, et al.
Publicado: (2023)

Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone
por: Aregawi, Maru, et al.
Publicado: (2016)

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
por: Haston, Julia C., et al.
Publicado: (2019)

Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya
por: Shuford, Kathryn, et al.
Publicado: (2016)

Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin–Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial
por: Yukich, Joshua O., et al.
Publicado: (2020)

‘Beyond “test and treat” – malaria diagnosis for improved pediatric fever management in sub-Saharan Africa’ by Emily White Johansson
por: Kachur, S. Patrick
Publicado: (2016)

Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration
por: Wu, Lindsey, et al.
Publicado: (2020)

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial
por: von Seidlein, Lorenz, et al.
Publicado: (2019)

Receptivity to malaria: meaning and measurement
por: Yukich, Joshua O., et al.
Publicado: (2022)

Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin–Piperaquine in Southern Province, Zambia
por: Finn, Timothy P., et al.
Publicado: (2020)

In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia
por: Hwang, Jimee, et al.
Publicado: (2011)

The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study
por: Peto, Thomas J, et al.
Publicado: (2018)

Mass drug administration for malaria elimination: do we understand the settings well enough?
por: Hetzel, Manuel W., et al.
Publicado: (2018)

Malaria resurgence after significant reduction by mass drug administration on Ngodhe Island, Kenya
por: Kagaya, Wataru, et al.
Publicado: (2019)

Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data
por: Fraser, Maya, et al.
Publicado: (2020)

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study
por: Brady, Oliver J, et al.
Publicado: (2017)

A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia
por: Dial, Natalie J, et al.
Publicado: (2014)

Zoonotic malaria requires new policy approaches to malaria elimination
por: Fornace, Kimberly M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0m1pn11jt3u3trm95nmidhnoq3